Universita' Degli Studi Di Perugia
- Address
- Strada Di Sant Andrea Delle Fratte, 06132 Perugia, Italy
Universita' Degli Studi Di Perugia - Multidisciplinary Clinical Research Center
The Universita' Degli Studi Di Perugia operates as a comprehensive clinical research institution with expertise spanning oncology, hematology, rheumatology, and cardiovascular medicine. The center demonstrates particular strength in investigating novel therapeutic approaches for rare and complex diseases, combining innovative immunotherapy strategies with traditional treatment modalities.
- Advanced oncology research including rare cancers such as Merkel cell carcinoma with chemo-immunotherapy protocols
- Hematologic malignancies with focus on multiple myeloma and pediatric Langerhans Cell Histiocytosis
- Autoimmune and inflammatory conditions including psoriatic arthritis with biologic therapy optimization
- Cardiovascular and renal disease research targeting pulmonary embolism and chronic kidney disease
The research portfolio reflects a commitment to both precision medicine and combination therapy strategies, with particular emphasis on optimizing treatment protocols through randomized controlled trials. The center's involvement in international collaborative studies demonstrates its role in advancing global standards of care across multiple therapeutic areas, from immunotherapy in solid tumors to novel approaches in cardiorenal protection.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita' Degli Studi Di Perugia
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN". | Fondazione Radioterapia Oncologica Onlus | Phase II | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apalutamide | 1 | Unknown | 2023-03-02 | 2023-03-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.